Cancer Genomics Clinical Trials Fund: SCCT Program
Overview
A one-off grant opportunity running over three years (FY2025-26 through FY2027-28) that directs additional investment to Australia's Multi-site Collaborative Cancer Clinical Trials Groups under the Support for Cancer Clinical Trials program. The fund aims to build capacity and develop methods to accelerate the incorporation of genomics into the design of cancer clinical trial concepts and protocols to benefit all CTGs.
Eligibility Requirements
Only Administering Bodies that represent the 14 nationally recognised Cancer Clinical Trials Groups participating in the SCCT program are eligible. Applicants must be organisations listed in Section 4.1 of the Grant Opportunity Guidelines. Joint consortia applications may be accepted.
Who Can Apply
Relevant Industries
How to Apply
Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.
Visit the official application page